Literature DB >> 2987621

Responsiveness of the in vitro hematopoietic microenvironment to platelet-derived growth factor.

M Rosenfeld, A Keating, D F Bowen-Pope, J W Singer, R Ross.   

Abstract

The adherent or stromal cells in human long-term marrow cultures, a possible in vitro counterpart of the in vivo microenvironment, were investigated for responsiveness to platelet-derived growth factor (PDGF). Many stromal cells from cultures derived from normal donors as well as from patients with chronic myelogenous leukemia, bore receptors to PDGF and were stimulated to incorporate [3H]-thymidine by highly purified PDGF and to a lesser extent by epidermal growth factor (EGF). These data suggest that PDGF and perhaps EGF may be involved in the regulation of the in vitro microenvironment and, therefore, of normal and possibly neoplastic hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987621     DOI: 10.1016/0145-2126(85)90001-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Response of bone marrow stromal cells to adipogenic antagonists.

Authors:  J M Gimble; M A Dorheim; Q Cheng; P Pekala; S Enerback; L Ellingsworth; P W Kincade; C S Wang
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

2.  Synthesis of platelet-derived growth factor by cells of splenic red pulp in normal rats.

Authors:  R E Dill; E K Miller; B J Dyer; A M Iacopino
Journal:  Cell Tissue Res       Date:  1994-04       Impact factor: 5.249

3.  Platelet-derived growth factor enhances granulopoiesis via bone marrow stromal cells.

Authors:  M Yang; K Li; A C Lam; P M Yuen; T F Fok; C N Chesterman; B H Chong
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

Review 4.  PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review).

Authors:  Hua-Zhong Ying; Qin Chen; Wen-You Zhang; Huan-Huan Zhang; Yue Ma; Song-Zhao Zhang; Jie Fang; Chen-Huan Yu
Journal:  Mol Med Rep       Date:  2017-09-27       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.